GSK Says Patent Deal Relevant To Abbott HIV Drug Suit
By Matthew Guarnaccia ( July 6, 2017, 4:47 PM EDT) -- GlaxoSmithKline told a North Carolina federal judge Wednesday that it should be allowed to argue in its lawsuit accusing Abbott Laboratories of violating a license agreement by raising the price of an HIV drug that Abbott undervalued some GSK patents in a reciprocal deal....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.